Coronavirus drug remdesivir is going to be hard to find in the US

$%name Coronavirus drug remdesivir is going to be hard to find in the US by Authcom, Nova Scotia\s Internet and Computing Solutions Provider in Kentville, Annapolis Valley$

Earlier this month, the FDA approved the drug remdesivir to treat patients hospitalized with COVID-19.
Shipments of remdesivir began going out last week, but only 607,000 of the 1,500,000 vials that drugmaker Gilead is donating are being distributed in the US.
There are over 300,000 patients eligible to receive remdesivir in the US, but the 607,000 vials are only enough to treat 78,000 hospitalized patients.
Visit BGR’s homepage for more stories.

Ever since the coronavirus reached the United States, there hasn’t been much good news to speak of. The national response was distressingly slow, the messaging was muddled, and as a result, the US was hit harder by SARS-CoV-2 than any other country. There was a faint ray of light earlier this month when the FDA authorized emergency use of a drug called remdesivir to treat COVID-19, but even that news now comes with a caveat.

Gilead Sciences Inc., the maker of the drug, has announced that it will donate 1.5 million vials of remdesivir over the next six weeks, but of those 1.5 million vials, 607,000 will stay in the United States. The US Department of Health and Human Services says that will be enough to treat 78,000 hospitalized patients. That sounds like a lot, but according to Bloomberg, there are more than 300,000 patients eligible to receive the drug in the US.

Continue reading…

Today’s Top Deals

Trending Right Now:

Coronavirus drug remdesivir is going to be hard to find in the US originally appeared on BGR.com on Mon, 11 May 2020 at 16:14:40 EDT. Please see our terms for use of feeds.